Home /  Ascensia Contour Next (Bayer)

Ascensia Contour Next (Bayer)

Device Name:Contour Next
Manufacturer:Sole: Bayer Healthcare AG, Kaiser-Willhelm-Allee, Building W11, 51368 Leverkusen, GERMANY.
Measuring functions:Blood glucose
Primary Client Use:Intended for both professional use and self-measurement
Measurement Site:Finger and general Alternative Site Testing
Measurement Occurrence:Single measurements only
Availability:Available Currently
Description: The Ascensia Contour Next (Bayer) is a clinically validated and 3-star blood glucose meter. Measurements are normally taken from the finger but alternative site testing is allowed and it is intended for both professional use and self-measurement.
Assessment:

The technology used in the Ascensia Contour Next (Bayer), to measure blood glucose, is among the best rated for accuracy by Medaval Ltd. It has passed in clinical validation studies, between general and specific populations, according to recognised standard protocols, as published in peer-reviewed publications.

Accuracy AssessmentRecommendationBasis
Medaval★★★ RecommendationRecent clinical validation; recent protocol; multiple clinical validations
Institute of Health Economics (CA)General useNo evidence provided
MDR CriteriaChildren and neonatesPublished evidence
 
Consumer BodyYear(s)LevelComment
Consumer Reports (US)Previous: 2019Excellent 
Choice (Australia)Latest: 2019A 
Amazon Best Sellers (US)Latest: 2019A (4.1 / 5) 

Validation Publications

DeSalvo DJ, Shanmugham S, Ly TT, Wilson DM, Buckingham BA. Accuracy evaluation of blood glucose monitoring systems in children on overnight closed-loop control. J Diabetes Sci Technol. 2014 Sep;8(5):969-73. Epub: 2014 May 21. doi: 10.1177/1932296814532238. PMID: 24876427. Available from: PMC4455362.

15197:2003 - Pass Children (Note: Modified protocol)

15197:2013 - Pass Children (Note: Modified protocol)

Dietzen DJ, Nenninger DA, Simmons DA, Pardo S, Pandya M, Fullam J. Analytic characteristics of three Bayer contour blood glucose monitoring systems in neonates. J Diabetes Sci Technol. 2015 Mar;9(2):257-61. Epub: 2014 Nov 4. doi: 10.1177/1932296814557669. PMID: 25377056. Available from: PMC4604584.

15197:2013 - Pass Neonates

CLSI:2013 - Pass Neonates

FDA:2016P - Fail Neonates

Klonoff DC, Parkes JL, Kovatchev BP, Kerr D, Bevier WC, Brazg RL, Christiansen M, Bailey TS, Nichols JH, Kohn MA. Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors. Diabetes Care. 2018 Aug;41(8):1681-8. Epub: 2018 Jun 13. doi: 10.2337/dc17-1960. PMID: 29898901. Available from: www.diabetestechnology.org.

DTS:2016 - Pass General population

Relevant Publications

Klaff LJ, Brazg R, Hughes K, Tideman AM, Schachner HC, Stenger P, Pardo S, Dunne N, Parkes JL. Accuracy evaluation of contour next compared with five blood glucose monitoring systems across a wide range of blood glucose concentrations occurring in a clinical research setting. Diabetes Technol Ther. 2015 Jan;17(1):8-15. doi: 10.1089/dia.2014.0069. PMID: 25260047.

Measurements from the Ascensia (Bayer) Contour Next are compared to those from the Roche Accu-Chek Aviva Nano, the Abbott FreeStyle Lite, the J&J LifeScan OneTouch Ultra 2, the J&J LifeScan OneTouch Verio Pro and the Nipro Truetrack, though not in a formal validation.

Huang E, Demirel S, Bliss C, Savaser D, Castle JR. Reliability of the Dexcom G6 Continuous Glucose Monitor During Hyperbaric Oxygen Exposure. Diabetes Technol Ther. 2020 May;22(5):360-366. Epub: 2020 Feb 6. doi: 101089/dia20190390. PMID: 31916854. Available from: PMC7196364.

The Ascensia Contour Next was used as a reference device in this study.